[1] 芮素芳, 郭淑霞, 张景玉, 等. 汉族及哈萨克族IL-6基因-174G/C多态性及CRP基因+1059G/C多态性与代谢综合征的相关性研究[J]. 现代预防医学, 2011,38(7):1312-1315. [2] 邵月琴, 向芳, 祝丽芳, 等. 上海市近郊地区35~74岁居民代谢综合征的流行特征调查分析 [J]. 中国全科医学, 2011,14(18):2069-2071. [3] 张玮, 王秋萍, 刘爱武, 等. 北京市农村中老年妇女代谢综合征的流行病学调查 [J]. 中国全科医学, 2010,13(10):1109-1111. [4] 陈冯梅, 郭志荣, 胡晓抒, 等. 代谢综合征与血脂异常及超敏C反应蛋白水平的关系 [J]. 中华内分泌代谢杂志, 2007,23(1):24-25. [5] Dehghan A, Kardys I, de Maat MP, et al. Genetic variation, C-reactive protein levels, and incidence of diabetes [J]. Diabetes, 2007,56(3):872-878. [6] Bajraktarevic A, Miokovic M, Pahor KA, et al. Level of CRP values as biomarker in childhood obesity [J]. Clin Biochem, 2011,44(7):522-523. [7] 陈建华, 戴红蕾, 方力争. 超敏C反应蛋白与代谢综合征的相关性研究 [J]. 中华急诊医学杂志, 2008,17(3):302-305. [8] Strazzullo P, Barbato A, Siani A, et al. Diagnostic criteria for metabolic syndrome: a comparative analysis in an unselected sample of adult male population [J]. Metabolism, 2008,57(3):355-361. [9] Tillett WS, Francis T. Serological reaction in pneumonia with a non-protein somatic fraction of pneumococcus [J]. J Exp Med, 1930,52(4):561-571. [10] Ndumele CE, Nasir K, Conceicao RD, et al. Hepatic steatosis, obesity, and the metabolic syndrome are independently and additively associated with increased systemic inflammation [J]. Arterioscler Thromb Vasc Biol, 2011,31(8):1927-1932. [11] Stefanska A, Sypniewska G, Blaszkiewicz B, et al. Comparison between C-reactive protein and adipocyte fatty acid-binding protein as a component of metabolic syndrome in middle-aged women [J]. Clin Biochem, 2011,44(4):304-306. [12] Tilg H, Moschen AR. Insulin resistance, inflammation, and non-alcoholic fatty liver disease [J]. Trends Endocrinol Metab, 2008,19(10):371-379. [13] Calabro P, Yeh ET. Intra-abdominal adiposity, inflammation, and cardiovascular risk: new insight into global cardiometabolic risk [J]. Curr Hypertens Rep, 2008,10(1):32-38. [14] 冯瑞儿, 郑琳颖, 吕俊华, 等. 白芍总苷对代谢综合征-高血压大鼠改善胰岛素敏感性、降压和抗氧化作用 [J]. 中国临床药理学与治疗学, 2010,15(2):154-159. [15] Dandona P, Aljada A, Chaudhuri A, et al. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation [J]. Circulation, 2005,111(11):1448-1454. [16] Hsu LA, Chang CJ, Wu S, et al. Association between functional variants of the ICAM1 and CRP genes and metabolic syndrome in Taiwanese subjects [J]. Metabolism, 2010,59(12):1710-1716. [17] Indulekha K, Surendar J, Mohan V. High Sensitivity C-Reactive Protein, Tumor Necrosis Factor-alpha, Interleukin-6, and Vascular Cell Adhesion Molecule-1 Levels in Asian Indians with Metabolic Syndrome and Insulin Resistance (CURES-105) [J]. J Diabetes Sci Technol, 2011,5(4):982-988. [18] Pradhan AD, Manson JE, Rifai N, et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus [J]. JAMA, 2001,286(3):327-334. |